Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India


  • Lupin has launched favipiravir in India under the brand name ‘Covihalt’ for the treatment of mild to moderate COVID-19
  • Covihalt will be available as 200mg tablets in the form of a strip of 10 tablets, priced at $0.65 (₹49/tablet) and has received DCGI authorization for emergency use
  • Additionally, SunPharma has launched antiviral drug favipiravir under the brand name ‘FluGuard’ to treat mild to moderate cases of COVID-19, at ₹35/tablet in India

Lupin, SunPharma ­to­ read full press release/ article  | Image: StraitTimes